Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Aug;72(4):261-5.

Differences in clinical manifestations of genital chlamydial infections related to serovars

Affiliations

Differences in clinical manifestations of genital chlamydial infections related to serovars

M J van de Laar et al. Genitourin Med. 1996 Aug.

Abstract

Objectives: To study the association of serovars of Chlamydia trachomatis with clinical manifestations of genital tract infection and socio-demographic characteristics.

Methods: In 1986-88 the C trachomatis isolates from 159 heterosexual men and 116 women attending a sexually transmitted disease (STD) clinic were collected and typed accordingly. A medical history was recorded, a physical examination took place and samples were taken for laboratory diagnostics.

Results: Serovars E, F and D were the most common for both men (75%) and women (67%). Men infected with serovars of the C-complex had more often a history of STD (p = 0.06). The opposite was demonstrated in women (p = 0.07). In addition, women younger than 18 years at first intercourse were more often infected with C-complex serovars (p = 0.05). For men, the serovars F/G less often produced symptoms of urethral discharge (p = 0.01) than the serovars of the B-complex and C-complex and were less often associated with the presence of 10 or more leukocytes in a Gram-stained smear (p = 0.04).

Conclusions: In this study, infections with serovars F and G caused less obvious symptoms and signs of inflammation in men; in women no differences were found in the clinical manifestation of infections with different serovars.

PubMed Disclaimer

References

    1. Genitourin Med. 1995 Dec;71(6):375-81 - PubMed
    1. J Clin Microbiol. 1994 Dec;32(12):2968-74 - PubMed
    1. N Engl J Med. 1978 Feb 23;298(8):428-35 - PubMed
    1. N Engl J Med. 1981 Jul 23;305(4):195-200 - PubMed
    1. Infect Immun. 1983 Aug;41(2):865-8 - PubMed

MeSH terms